Regan Fong

发表

Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.

S. Kutcher, K. Wagner, G. Emslie, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance

Regan Fong, Marc W Morris, L. Schifano, 2016, The Journal of dermatological treatment.

Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorder.

K. Wagner, J. Horrigan, S. Krulewicz, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers

M. Versavel, H. Naik, J. Palmer, 2020, Clinical and translational science.

Effects of a State‐ and Use‐Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover Study

W. White, H. Naik, J. Palmer, 2018, Journal of clinical pharmacology.

Evaluation of the safety, pharmacokinetics, pharmacodynamics, and drug-drug interaction potential of a selective Lp-PLA2 inhibitor (GSK2647544) in healthy volunteers

Yanmei Xu, A. Lockhart, X. Yao, 2016, International journal of clinical pharmacology and therapeutics.

Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine.

A. Metz, A. Apter, S. Krulewicz, 2006, Journal of child and adolescent psychopharmacology.

Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy.

J. Kraus, J. Horrigan, D. Carpenter, 2010, Journal of affective disorders.

Multiple Dose Pharmacokinetics of Paroxetine in Children and Adolescents with Major Depressive Disorder or Obsessive–Compulsive Disorder

G. Nucci, R. Findling, A. Gaedigk, 2006, Neuropsychopharmacology.

An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder.

R. Berard, D. Carpenter, Christel Wilkinson, 2006, Journal of child and adolescent psychopharmacology.

Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitor [18F]GSK2647544 in Healthy Male Subjects

J. Passchier, E. Rabiner, Yanmei Xu, 2016, Molecular Imaging and Biology.

Interaction of the opiate and NMDA systems in a spatial learning task

E. Bostock, K. E. McKay, Regan Fong, 1992, Psychobiology.

Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.

M. Thase, J. Kraus, D. Carpenter, 2011, The Journal of clinical psychiatry.

RVT-1401, A Novel Anti-FcRn Monoclonal Antibody, Is Well Tolerated in Healthy Subjects and Reduces Plasma IgG Following Subcutaneous or Intravenous Administration (P5.2-079)

S. Piscitelli, P. Griffin, L. Webster, 2019 .